Home Cart Sign in  
Chemical Structure| 70261-81-3 Chemical Structure| 70261-81-3

Structure of 70261-81-3

Chemical Structure| 70261-81-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 70261-81-3 ]

CAS No. :70261-81-3
Formula : C12H17N3O2
M.W : 235.28
SMILES Code : O=[N+](C1=CC=C(C=C1)CN2CCN(C)CC2)[O-]
MDL No. :MFCD00976866
InChI Key :TZZWNVPIAQKNTG-UHFFFAOYSA-N
Pubchem ID :677795

Safety of [ 70261-81-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Application In Synthesis of [ 70261-81-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 70261-81-3 ]

[ 70261-81-3 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 109-01-3 ]
  • [ 555-16-8 ]
  • [ 70261-81-3 ]
YieldReaction ConditionsOperation in experiment
90% With sodium tetrahydroborate; acetic acid In chloroform at 0 - 20℃; for 13 h; General procedure: AcOH (100percent) (140 mL, 2.44 ml) was added over 1 h to a flask containing stirred NaBH4 (20.0 g, 0.53 ml) and CHCl3 (220 mL) at 0-5 °. The resulting mixture was stirred at 0-5 ° for 1.5 h and 1-methylpiperazine (1) (28.0 ml, 0.25 ml) and a solution of methyl 4-formylbenzoate (2a) (43.4 g, 0.26 ml) in CHCl3 (60 mL) were added. The resulting mixture was stirred at 0-5 ° for 1 h and then for 12 h at rt. the mixture was treated with H2O (150 mL) and Na2CO3 until pH 8.0-9.0. The aqueous phase was extracted with EtOAc (2 .x. 100 ml) then both organic layers were combined, washed with H2O (1 .x. 100 ml), and dried over anhydrous Na2SO4. Filtration and evaporation of the solvents gave methyl 4-[(4-methylpiperazin-1-yl)methyl]benzoate (4a): yellowish oil; yield: 61.6 g, 99percent.
References: [1] Tetrahedron Letters, 2012, vol. 53, # 38, p. 5056 - 5058.
[2] Russian Journal of Organic Chemistry, 2013, vol. 49, # 4, p. 563 - 567[3] Zh. Org. Khim., 2013, vol. 49, # 4, p. 580 - 584.
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 21, p. 8801 - 8815.
[5] Russian Journal of Organic Chemistry, 2011, vol. 47, # 10, p. 1556 - 1563.
  • 2
  • [ 109-01-3 ]
  • [ 100-11-8 ]
  • [ 70261-81-3 ]
YieldReaction ConditionsOperation in experiment
92% With potassium carbonate; potassium iodide In acetonitrile for 5 h; 4-nitrobenzylbromide (4.30 g, 20 mmol) was dissolved in 40 ml of acetonitrile solvent,Then K2CO3 (5.52 g, 40 mmol) was added,KI (0.33 g, 2 mmol),Then, 4-methylpiperazine (2.20 g, 22 mmol) was added thereto,After 5 h, the reaction was complete.The reaction solution was concentrated and dried,And further adding 100 ml of H2O thereto,Extracted with ethyl acetate (150 ml x 3)The organic layer was collected, concentrated,4.32 g of a solid was obtained in 92percent yield.
References: [1] Medicinal Chemistry Research, 1999, vol. 9, # 3, p. 149 - 161.
[2] Patent: CN106432235, 2017, A, . Location in patent: Paragraph 0220; 0221.
[3] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 15, p. 5738 - 5748.
[4] Patent: WO2005/54238, 2005, A1, . Location in patent: Page/Page column 88.
[5] Chemical and Pharmaceutical Bulletin, 2014, vol. 62, # 3, p. 238 - 246.
[6] Patent: EP2955185, 2015, A1, . Location in patent: Paragraph 0079.
[7] Patent: CN103739550, 2016, B, . Location in patent: Paragraph 0173-0176.
[8] European Journal of Medicinal Chemistry, 2017, vol. 130, p. 86 - 106.
[9] Patent: CN107245073, 2017, A, . Location in patent: Paragraph 0121; 0122; 0123.
[10] Journal of Medicinal Chemistry, 2017, vol. 60, # 21, p. 8801 - 8815.
[11] Journal of Medicinal Chemistry, 2018, vol. 61, # 4, p. 1499 - 1518.
[12] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 303 - 315.
  • 3
  • [ 109-01-3 ]
  • [ 100-14-1 ]
  • [ 70261-81-3 ]
YieldReaction ConditionsOperation in experiment
50% at 20℃; for 24 h; The First Step:
Preparation of 1-methyl-4-(4-nitrobenzyl)-piperazine (F652-01)
Monomethylpiperazine (15 mL) and tetrahydrofuran (60 mL) were placed in a 200 mL eggplant shaped flask, and a solution of 4-nitrobenzylchloride (8.58 g, 50 mmol) in tetrahydrofuran was added dropwise to the mixture at room temperature while stirring.
After finishing the instillation, the mixture was stirred at room temperature for 24 hours.
The reaction mixture was mixed with distilled water, and the precipitated solids were collected by filtration and dried under reduced pressure to obtain the title compound (5.9 g, 50percent). LC/MS (Method 3): m/z (ESI, POS): 236[M+H]+; retention time: 1.28 minutes.
59% With sodium carbonate; triethylamine In ethylene glycol A.
1-methyl-4-[(4-nitrophenyl)methyl]piperazine
To a solution of p-nitrobenzyl chloride (5.2 g, 10mM) and 3.2 g of triethylamine in 30 ml of ethylene glycol is added a solution of N-methylpiperazine (3 g, 30 mM) in 20 ml of ethylene glycol.
After complete addition, the resulting solution is heated to 80° C. under nitrogen for 30 minutes.
The reaction mixture is quenched into aqueous 10percent sodium carbonate solution and extracted with methylene chloride.
The methylene chloride solution is washed with water, saturated sodium chloride solution, dried over anhydrous sodium sulfate and concentrated to give 4.15 g (59percent) of 1-methyl-4-[(4-nitrophenyl)methyl]piperazine.
References: [1] Farmaco, 1992, vol. 47, # 3, p. 335 - 344.
[2] Patent: EP1857446, 2007, A1, . Location in patent: Page/Page column 45.
[3] Patent: WO2008/94575, 2008, A2, . Location in patent: Page/Page column 52-53.
[4] European Journal of Medicinal Chemistry, 2011, vol. 46, # 7, p. 2917 - 2929.
[5] Patent: US4140775, 1979, A, .
  • 4
  • [ 109-01-3 ]
  • [ 70261-81-3 ]
References: [1] Patent: WO2006/88949, 2006, A1, . Location in patent: Page/Page column 178-180.
  • 5
  • [ 109-01-3 ]
  • [ 100-00-5 ]
  • [ 70261-81-3 ]
YieldReaction ConditionsOperation in experiment
99% at 90℃; for 18 h; 31.5 g of 4-chloro-1-nitrobenzene and 44.4 ml of 1-methyl-piperazine are combined and stirred for 18 hours at 90° C. Then the solution is poured onto ice water and the precipitate formed is suction filtered, washed with water and recrystallised from ethanol/water (1:1). The residue is dried in vacuo at 75° C. [00369] Yield: 44.0 g (99percent of theory), [00370] Rf value: 0.5 (silica gel, methylene chloride/methanol=10:1) [00371] Melting point: 108-112° C.
References: [1] Patent: US6794395, 2004, B1, . Location in patent: Page/Page column 23.
  • 6
  • [ 1015484-22-6 ]
  • [ 100-00-5 ]
  • [ 70261-81-3 ]
References: [1] Synlett, 2011, # 3, p. 349 - 356.
  • 7
  • [ 1015484-22-6 ]
  • [ 586-78-7 ]
  • [ 70261-81-3 ]
References: [1] Synlett, 2011, # 3, p. 349 - 356.
  • 8
  • [ 109-01-3 ]
  • [ 555-16-8 ]
  • [ 7556-55-0 ]
  • [ 619-73-8 ]
  • [ 70261-81-3 ]
References: [1] Chemistry of Heterocyclic Compounds, 2007, vol. 43, # 12, p. 1540 - 1543.
  • 9
  • [ 99-99-0 ]
  • [ 70261-81-3 ]
References: [1] European Journal of Medicinal Chemistry, 2017, vol. 130, p. 86 - 106.
[2] Journal of Medicinal Chemistry, 2017, vol. 60, # 21, p. 8801 - 8815.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 70261-81-3 ]

Aryls

Chemical Structure| 16155-08-1

A156310 [16155-08-1]

1-Benzyl-4-(4-nitrophenyl)piperazine

Similarity: 0.93

Chemical Structure| 15184-96-0

A185942 [15184-96-0]

N,N-Dimethyl-1-(4-nitrophenyl)methanamine

Similarity: 0.92

Chemical Structure| 19499-61-7

A201245 [19499-61-7]

N-Methyl-1-(3-nitrophenyl)methanamine

Similarity: 0.86

Chemical Structure| 5729-06-6

A165152 [5729-06-6]

N-Benzyl-2-nitroaniline

Similarity: 0.84

Chemical Structure| 10439-77-7

A164598 [10439-77-7]

N,2-Dimethyl-4-nitroaniline

Similarity: 0.81

Nitroes

Chemical Structure| 16155-08-1

A156310 [16155-08-1]

1-Benzyl-4-(4-nitrophenyl)piperazine

Similarity: 0.93

Chemical Structure| 15184-96-0

A185942 [15184-96-0]

N,N-Dimethyl-1-(4-nitrophenyl)methanamine

Similarity: 0.92

Chemical Structure| 19499-61-7

A201245 [19499-61-7]

N-Methyl-1-(3-nitrophenyl)methanamine

Similarity: 0.86

Chemical Structure| 5729-06-6

A165152 [5729-06-6]

N-Benzyl-2-nitroaniline

Similarity: 0.84

Chemical Structure| 42923-79-5

A315838 [42923-79-5]

7-Nitro-1,2,3,4-tetrahydroisoquinoline

Similarity: 0.82

Related Parent Nucleus of
[ 70261-81-3 ]

Piperazines

Chemical Structure| 16155-08-1

A156310 [16155-08-1]

1-Benzyl-4-(4-nitrophenyl)piperazine

Similarity: 0.93

Chemical Structure| 21091-98-5

A189921 [21091-98-5]

(4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone

Similarity: 0.78

Chemical Structure| 451459-92-0

A838692 [451459-92-0]

2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile

Similarity: 0.78

Chemical Structure| 54054-85-2

A674336 [54054-85-2]

1-(3-Nitrophenyl)piperazine

Similarity: 0.75

Chemical Structure| 611225-86-6

A147237 [611225-86-6]

4-(4-Ethylpiperazin-1-ylmethyl)phenylamine

Similarity: 0.72